Posted by Michael Wonder on 10 Apr 2019
Sanofi sets a fixed price of insulin at $99 per month for some patients
10 April 2019 - Sanofi says it will sell monthly supplies of insulin for a fixed price of $99 to patients paying with cash.
Sanofi said Wednesday it will sell monthly supplies of insulin for a fixed price of $99 for patients paying with cash in the U.S. as the pharmaceutical giant faces intense pressure from the Trump administration and Congress to lower the cost of its nearly 100-year-old, life-saving medication.
The move is a pre-emptive one as the French drug maker is set to testify before the House Energy and Commerce Committee on the rising prices of insulin later in the day. Executives from insulin producers Eli Lilly and Novo Nordisk are also set to testify in the hearing titled, “Priced out of a lifesaving drug: Getting answers on the rising cost of insulin.”
Sanofi said people can buy up to 10 products — whether vials, pens or a mix of both — for $99. This includes all of Sanofi’s insulin brands. Sanofi first introduced the program ”“Insulins Valyou Savings” last year, though it was more expensive. One 10 mL vial of insulin cost $99 and a box of pens cost $149, meaning that people who needed multiple items could end up paying hundreds of dollars. Patients can participate in the program regardless of their income level.
